Ask AI

Lymphoma and Leukemia

For coverage of gastrointestinal, lung, and breast cancers at ASCO 2026, click here.

Share

Program Content

Activities

  • frontMIND
    frontMIND: Phase III Trial of Tafasitamab + Lenalidomide + R-CHOP vs R-CHOP for Newly Diagnosed DLBCL
    Capsule Summary
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 23, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education

Supporters

This activity is supported by educational grants from Incyte Corporation, Lilly, and Novartis Pharmaceuticals Corporation.

Incyte Corporation

Lilly

Novartis Pharmaceuticals Corporation